Bionyra
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases.
$165M Series A ·
Led by Jeito Capital · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJun 16, 2025 (17 months old)
About Bionyra
Bionyra’s
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $165M | fundraisingfox.com |
Timeline
- Website created
Founders and team
FM
Frédéric Marrache co-founderLinkedIn · source: bionyra.com
Investors
AApollo Health Ventures
AArkin Capital
JJeito Capitallead investor
LLMO
SSanofi Ventures
SSixty Degree Capital
SSofinnova Partnerslead investor
VVIVES Funds
Companies like Bionyra
MMirador Therapeutics$250M Series B+ · Jan 2026
CCitryll$92.5M Series B+ · Dec 2024
EEngimmune Therapeutics$16M Seed · May 2022
SSudo Bio$37M Series A · Sep 2022HHI-Bio$95M Series B+ · Jan 2024
FFreya BiosciencesSeries A · Nov 2024
Other companies backed by Jeito Capital
AAzafaros$150M Series B+ · May 2025
AAugustine Therapeutics$85M Series A · Mar 2025
CCatalYm$150M Series B+ · Jul 2024
NNMD Pharma$80M Series B+ · Nov 2023
PPulmocide$52M Series B+ · Dec 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/bionyra (get a free API key).